Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
The Best Games On the planet - 2Guaranteeing Quality Medical care with Federal medical care Benefit Plans.
- 3Step by step instructions to Pick A Keep money with High Fixed Store Loan costs
- 4Most loved Public Dish: Which One Addresses Its Nation Best?
- 5Nitty gritty Manual for Picking Agreeable Tennis shoes
- Did we start the fire? A 400,000-year-old hearth sparks new questions about human evolution
- The Universe of Impeccable Pearls: A Manual for Valuable Gems
- Farmers call for French blockades over cow disease cull
- Must-Sit in front of the Programs from Europe and the US
- Choosing Moving Styles for Your Restroom Redesign
- The Most Compelling Books of the 10 years
- Bismuth’s haredi draft bill won’t change enlistment, IDI expert tells 'Post'
- Vote In favor of Your Favored Web-based Venture Stage
- This Week In Space podcast: Episode 188 — A New NASA Leader Rises?
